1444 Pharmacologic LDH inhibition redirects intratumoral glucose consumption and improves response to CTLA-4 blockade
Main Authors: | Jedd D Wolchok, Taha Merghoub, Sadna Budhu, Roberta Zappasodi, Svena Verma, Inna Serganova, Lauren Dong, Levi Mark Mangarin, Yacine Marouf, Jonathan F Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
525 Investigating dynamic IDO-Kyn-AhR pathway-induced tumor immunosuppression using imaging modality to optimize AhR therapeutic intervention
by: Jedd D Wolchok, et al.
Published: (2023-11-01) -
968 PD-1hiFoxp3-CD4+ tumor-infiltrating T-cell lineage commitment impacts the immunotherapy outcome
by: Jedd D Wolchok, et al.
Published: (2023-11-01) -
789 Immune checkpoint blockade augments cyclophosphamide induced anti-tumor immunity by expanding effector CD8+ T cell clones in a preclinical melanoma model
by: Alan N Houghton, et al.
Published: (2023-11-01) -
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
by: Arnab Ghosh, et al.
Published: (2022-09-01) -
Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer
by: Aditi Gupta, et al.
Published: (2021-11-01)